Use of drugs to protect against fetal asphyxia.
D000818:Animals; D000831:Animals, Newborn; D000863:Antacids / Q000627:therapeutic use; D001238:Asphyxia Neonatorum / Q000517:prevention & control*; D004111:Dimenhydrinate / Q000627:therapeutic use; D005260:Female; D005333:Fetus / Q000187:drug effects*; D005632:Fructose / Q000627:therapeutic use; D005947:Glucose; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D006931:Hyperbaric Oxygenation; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D007231:Infant, Newborn; D008431:Maternal-Fetal Exchange; D009294:Narcotics / Q000627:therapeutic use; D010276:Parasympatholytics / Q000627:therapeutic use; D011247:Pregnancy; D011270:Pregnancy, Animal; D011817:Rabbits; D012151:Resuscitation; D012601:Scopolamine / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000627:therapeutic use
D000863:Antacids; D006634:Histamine H1 Antagonists; D006993:Hypnotics and Sedatives; D009294:Narcotics; D010276:Parasympatholytics; D014149:Tranquilizing Agents; D005632:Fructose; D012601:Scopolamine; D005947:Glucose; D004111:Dimenhydrinate